clinical trial · NCT07090161
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
HypertensionUncontrolled HypertensioniloperidonePlacebo
brief summary
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension
started
Sep 15, 2025
primary completion
Oct 1, 2026
completion
Nov 1, 2026
last updated
Feb 27, 2026
official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol